According to our latest research, the global Circulating Tumour Cells (CTCs) market size reached USD 8.1 billion in 2024, with a robust compound annual growth rate (CAGR) of 16.2% projected through the forecast period. By 2033, the CTCs market is forecasted to attain a valuation of USD 36.7 billion, driven by technological advancements, increased prevalence of cancer, and the growing adoption of liquid biopsy techniques. The market's expansion is underpinned by the rising demand for non-invasive diagnostic solutions, which are becoming integral in cancer management and personalized medicine.
https://growthmarketreports.com/report/circulating-tumour-cells-global-industry-analysis
https://growthmarketreports.com/report/circulating-tumour-cells-global-industry-analysis
According to our latest research, the global Circulating Tumour Cells (CTCs) market size reached USD 8.1 billion in 2024, with a robust compound annual growth rate (CAGR) of 16.2% projected through the forecast period. By 2033, the CTCs market is forecasted to attain a valuation of USD 36.7 billion, driven by technological advancements, increased prevalence of cancer, and the growing adoption of liquid biopsy techniques. The market's expansion is underpinned by the rising demand for non-invasive diagnostic solutions, which are becoming integral in cancer management and personalized medicine.
https://growthmarketreports.com/report/circulating-tumour-cells-global-industry-analysis
0 Комментарии
0 Поделились
25 Просмотры